Press release -
Ready for the NLSDays 2019
This year, CTC will be represented by Anders Millerhovf, CEO, Bengt Dahlström, CSO, and Fredrik Hansson, Director Biometrics. They are all part of our Customer Relations team and will tell you how we translate science into treatment through our true full-service package for phase 0-II clinical trials, including clinical conduct at our first-in-human approved clinic.
During the event we will share booth with Immuneed and will be happy to discuss our joint “Preclinical Human Model” approach to early drug development. In a close partnership we offer a total solution for the preclinical and clinical characterization of a drug conferring a thorough risk mitigation strategy where the safety of the research subjects always comes first.
You will find us in booth #54. See you soon!
Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and healthtech but also from finances, research, policy and regulatory authorities.
Topics
- Medical research
Categories
- nlsdays
CTC Clinical Trial Consultants AB is a full-service CRO with focus on clinical conduct. Our mission is to facilitate clinical and translational research by providing our customers with cost-effective advice, conduct and reporting of clinical trials. We have four different departments: Clinic, Clinical Operations, Pharmacovigilance and Biometrics, all supported by independent quality assurance management.
Our head office and Phase 1 units are located in Uppsala comprising 28 beds of which 12 are hospital beds in a first-in-human approved research unit whereas our two professional sites for multicenter studies (SMOs) are found in Uppsala and Linköping. We have our own subject database for recruitment of both healthy volunteers and special patient populations.
CTC was founded in 2011 and has successfully conducted over 200 industry sponsored clinical trials for start-up companies as well as for international pharmaceutical companies and CROs. Our track record includes first-in-human, food effect, drug interaction, bioequivalence, bioavaliability and biosimilar studies, new drug delivery systems, medical device, PET/MR, QT and Phase IIa studies.
